Creative Bioarray has developed our unique CRISPR/Cas9 cellular gene knockout/knockin platform to accurately knockout/knockin specified genes. Compared with traditional TALENs (transcription activator-like effector nucleases) and ZNFs (zinc finger nucleases), CRISPR enables efficient and flexible gene knockout/knockin at a competitive cost. Our scientists are experienced in using CRISPR/Cas9 to provide single-gene, dual-gene, or gene fragment knockout, from gRNA construction to transfection and monoclonal generation of various host cell lines such as HEK293T, HeLa, HCT116, HepG2, A549 and other difficult-to-transfect immortalized cell lines.
Creative Bioarray's groundbreaking CD-CRISPR platform delivers industrial CRISPR-engineered cells with the gene knockout or knockin sequence you need. We do not shy away from editing primary cells, iPSCs, TERT immortalized cell lines, or other sensitive cell lines - adherent or suspension. Since we work vector-free, we also offer complex edits such as knockin (KI) with large repair templates or multiple knock-outs (e.g. triple knock-out). Choose from >100 immortalized or induced pluripotent (iPS) cell lines available.
We do not shy away from editing primary cells, iPSCs, TERT immortalized cell lines, or other sensitive cell lines.
Creative Bioarray's proprietary RNA synthesis platform offers flexibility in length and modification to achieve optimal results for the most complex projects.
Every CRISPR knockout cell line is guaranteed so you can trust your downstream assay results.
Creative Bioarray is the world leading biological company whose mission focuses on the acquisition, authentication, production, and development of standard reference microbial strains, and cell lines.
